This announcement is a separate document:
中國再生醫學：2023年第三季季度報告
CRMI: Third Quarterly Report 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.